advertisement
Packer M 9
Showing records 1 to 9 | Display all abstracts from Packer M69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Vold S
Ophthalmology 2016; 123: 2103-2112
70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Ianchulev T; Chayet A
Therapeutic delivery 2016; 7: 751-760
69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Ahmed II
Ophthalmology 2016; 123: 2103-2112
70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Kahook M
Therapeutic delivery 2016; 7: 751-760
69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Craven ER
Ophthalmology 2016; 123: 2103-2112
70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Packer M
Therapeutic delivery 2016; 7: 751-760
69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Mattox C; Stamper R
Ophthalmology 2016; 123: 2103-2112
70355 Pharmacodynamic profile of mydriatic agents delivered by ocular piezo-ejection microdosing compared with conventional eyedropper
Pasquale L; Weinreb RN
Therapeutic delivery 2016; 7: 751-760
69962 Two-Year COMPASS Trial Results: Supraciliary Microstenting with Phacoemulsification in Patients with Open-Angle Glaucoma and Cataracts
Packer M; Brown RH; Ianchulev T;
Ophthalmology 2016; 123: 2103-2112